Al Rostamani Group, a diversified conglomerate in the UAE, has donated Dh10 million ($2.72 million) to non-profit organisation Al Jalila Foundation as funding for life-changing medical research.

“It is no easy feat to bring medical miracles within reach, and Al Jalila Foundation needs all the support it can get. By contributing in our own small way, I sincerely hope to motivate other philanthropists to join this movement for medical innovations so that the UAE can make a profound mark on the medical world,” Al Rostamani, chairman of Al Rostamani Group said, was quoted as saying by Gulf News in a report.

“If we hope to position the UAE at the frontiers of advanced health care, we need to set the groundwork today through more research contributions. Modern lifestyles are evolving and raising new health challenges, so our biomedical research must also evolve to stay a step ahead,” said Dr Abdul Kareem Sultan Al Olama, CEO of Al Jalila Foundation.

The foundation aims to raise Dh100 million in 2013. Its first project, Ta’alouf, has its focus on children’s developmental disorders, including conditions that may impair a child’s physical, behavioural, learning or language skills, the report said.